The blockage of the growth of new blood vessels in tumors by the inhibition of the epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) has been successfully tested against CRC [36,37]. The gene discussed is VEGFA; the disease is colorectal carcinoma.